Edwards Lifesciences (EW) Asset Utilization Ratio (2010 - 2026)

Edwards Lifesciences' Asset Utilization Ratio history runs 17 years deep, the most recent figure standing at 0.47 for Q1 2026.

• In Q1 2026, Asset Utilization Ratio rose 10.17% year-over-year to 0.47; the TTM figure through Mar 2026 stood at 0.47 (up 10.17% YoY), while the FY2025 annual figure was 0.45, down 6.52% from the prior year.
• Asset Utilization Ratio was 0.47 for Q1 2026 at Edwards Lifesciences, up from 0.45 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.64 in Q2 2022 to a low of 0.42 in Q4 2024.
• Historically, Asset Utilization Ratio has averaged 0.5 across 5 years, with a median of 0.48 in 2023.
• The sharpest annual moves came in 2023 and 2026: Asset Utilization Ratio retreated 27.74% in 2023, then gained 10.17% in 2026.
• A 5-year view of Asset Utilization Ratio shows it stood at 0.53 in 2022, then climbed by 1.43% to 0.53 in 2023, then decreased by 21.85% to 0.42 in 2024, then advanced by 7.65% to 0.45 in 2025, then gained by 3.7% to 0.47 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.47 (Q1 2026), 0.45 (Q4 2025), and 0.44 (Q3 2025), per Business Quant data.